Cleveland Clinic Vasculitis Advances and Controversies 2025

Cleveland Clinic Vasculitis Advances and Controversies 2025

22 videos + 18 pdfs, size: 10.2 GB

Rheumatologic and immunologic diseases demand nuanced management of complex, often overlapping conditions. Biologic therapies, treat-to-target strategies, and emerging immunomodulators are transforming outcomes.

The Cleveland Clinic has been ranked #1 in cardiology for over two decades and stands among the world’s most respected academic medical centers. This course reflects that excellence.

💎 What You’ll Master

• Critically appraise emergent treatment options in small vessel vasculitis and large vessel vasculitis
• Evaluate CNS involvement in vasculitis
• Evaluate current and future landscape of glucocorticoid use in vasculitis management
• Discuss imaging advancement in large vessel vasculitis and other diagnostic modalities in vasculitis
• Appraise the diagnostic modalities in giant cell arteritis
• Evaluate the clinical evidence supporting the use of tocilizumab as a first-line therapy in GCA
• Appraise the role of plasma exchange in ANCA-associated vasculitis

📚 Learning Format

Every module is designed for busy clinicians — structured for efficient learning, immediately applicable to practice, and built around evidence you can trust.

• High-definition video lectures from world-class faculty
• Downloadable slides and PDFs for offline reference
• Self-paced learning — no deadlines, no expiry
• Instant digital delivery — access within minutes of purchase

✅ What’s Included

• Complete package: 22 videos + 18 pdfs, size: 10.2 GB
• Instant digital delivery — access immediately after purchase
• Lifetime access — no expiry, no subscription
• Downloadable materials — study on any device, offline
• No monthly fees — one payment, permanent access

🚀 Who This Course Is For

This course is designed for rheumatologists, immunologists, internists, and advanced practice providers managing autoimmune and inflammatory disease with complex biologic and immunomodulatory therapies.